Argenx to present at upcoming investor conferences

February 26, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of the management team will participate in the following investor conferences in march:
ARGX Ratings Summary
ARGX Quant Ranking